67 results
Page 3 of 4
8-K
c24 4p1kvh
15 Apr 21
Other Events
7:00am
8-K
EX-99.1
34xit ilk5jfxz
18 Mar 21
Sutro Biopharma Reports Full Year 2020 Financial Results
7:00am
424B5
ci3a4 4k5z
9 Dec 20
Prospectus supplement for primary offering
4:02pm
424B5
kj6js
7 Dec 20
Prospectus supplement for primary offering
4:10pm
8-K
5jba ou287
7 Dec 20
Regulation FD Disclosure
3:45pm
8-K
EX-99.1
rdw0qjth uvqm
7 Dec 20
Regulation FD Disclosure
3:45pm
8-K
8ul7 o8sz
4 Dec 20
Sutro Biopharma Announces Encouraging Interim Data on STRO-002 Phase 1 Dose-Escalation Study for Patients with Ovarian Cancer
12:00am
8-K
EX-99.1
0cqnozf 87z0o1xq
4 Dec 20
Sutro Biopharma Announces Encouraging Interim Data on STRO-002 Phase 1 Dose-Escalation Study for Patients with Ovarian Cancer
12:00am
8-K
EX-99.2
hr6cclhk1miyj1 8r
4 Dec 20
Sutro Biopharma Announces Encouraging Interim Data on STRO-002 Phase 1 Dose-Escalation Study for Patients with Ovarian Cancer
12:00am
8-K
EX-99.1
zu4vv3zmho d0zjis1j
5 Nov 20
Sutro Biopharma Reports Third Quarter 2020 Financial Results
7:05am
8-K
EX-99.2
bc56k
9 Sep 20
Other Events
5:23pm
8-K
EX-99.1
3qbfr av2ixk0iik
9 Sep 20
Other Events
5:23pm
8-K
EX-99.1
3jc09mk37
6 Aug 20
Sutro Biopharma Reports Second Quarter 2020 Financial Results
7:03am
8-K
EX-99.1
zb2k0
15 Jun 20
Regulation FD Disclosure
7:21am
424B5
wme9ahhihp
12 May 20
Prospectus supplement for primary offering
5:02pm